'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform
By Jade Martinez-Pogue ( May 6, 2026, 7:09 PM EDT) -- Special purpose acquisition company Drugs Made In America Acquisition Corp. has filed plans with U.S. regulators to merge with tech company Power Analytics Global Corp. in a deal with a target enterprise valuation of $1 billion for Power Analytics....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.